Prescribing the deprescription: a review for a virtuous circle
DOI:
https://doi.org/10.11606/issn.1679-9836.v99i4p384-388Keywords:
Prescription drugs, Deprescriptions, BenzodiazepinesAbstract
Benzodiazepines (BZDs) are generally used without anxiety treatment, insomnia, alcohol withdrawal, delirium and seizures due to their anxiolytic, hypnotic, anticonvulsant and muscle relaxant activity. These drugs have not been consumed for almost two weeks, but have been recently found to be sick with up to 10 years use. In order to know the possibilities of presentation of the BZDs, a review based on the NCBI /PubMed (National Center for Biotechnology Information) and SciELO (Scientific Electronic Lirary Online) databases was carried out. The results of the analysis are the most heterogeneous regarding the BZDs splice notification and the best description to allow replication in clinical practice and research.
Downloads
References
Sgnaolin V, Engroff P, Andrade C, Loureiro F, Nogueira E, Cataldo Neto, A et al. Patterns of chronic benzodiazepine use in the elderly. Arch Clin Psychiatr. 2016;43(4):79-82. http://dx.doi.org/10.1590/0101-60830000000089.
Naloto D, Lopes F, Barberato Filho S, Lopes L, Del Fiol F, Bergamaschi C. Prescrição de benzodiazepínicos para adultos e idosos de um ambulatório de saúde mental. Ciên Saúde Coletiva. 2016;21(4):1267-76. http://dx.doi.org/10.1590/1413-81232015214.10292015.
Lee J, Farrell B, Holbrook A. De-prescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines. Polish Arch Intern Med. 2019;129(1):43-9. http://dx.doi.org/10.20452/pamw.4391.
Rodríguez OW, Turiel C, León S, González MJ, Simón M, Fernández Menéndez M. Deprescripción de benzodiacepinas y fármacos Z: una responsabilidad compartida. Rev Psiquiatr Salud Mental. 2018;11(3):184-5. https://doi.org/10.1016/j.rpsm.2018.01.003.
Limandri B. Benzodiazepine use: the underbelly of the opioid epidemic. J Psychosoc Nursing Mental Health Serv. 2018;56(6):11-5. https://doi.org/10.3928/02793695-20180521-03.
Reeve E, Ong M, Wu A, Jansen J, Petrovic M, Gnjidic D. A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. Eur J Clin Pharmacol. 2017;73(8):927-35. https://doi.org/10.1007/s00228-017-2257-8
Pollmann A, Murphy A, Bergman J, Gardner D. Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review. BMC Pharmacol Toxicol. 2015;16(1):16-9. https://doi.org/10.1186/s40360-015-0019-8.
Ng B, Le Couteur D, Hilmer S. Deprescribing benzodiazepines in older patients: impact of interventions targeting physicians, pharmacists, and patients. Drugs Aging. 2018;35(6):493-521. https://doi.org/10.1007/s40266-018-0544-4
Ogbonna C, Lembke A. Tapering patients of benzodiazepines. Am Fam Phys. 2017;26(9):606-8. PMID: 29094883.
Pottie K, Thompson W, Davies S, Grenier J, Sadowski C, Welch V, et al. Deprescribing benzodiazepine receptor agonists Evidence-based clinical practice guideline. Can Fam Phys. 2018;64:339-51.
Hintze J, Edinger J. Hypnotic discontinuation in chronic insomnia. Sleep Med Clin. 2018;13(2):263-70. http://dx.doi.org/10.1016/j.jsmc.2018.02.008.
Pruskowski J, Rosielle D, Pontiff L, Reitschuler-Cross E. Deprescribing and tapering benzodiazepines #355. J Palliative Med. 2018;21(7):1040-1. http://dx.doi.org/10.1089/jpm.2018.0264.
